Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ATIPNASDAQ:BLTENASDAQ:IRONNASDAQ:SNDA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATIPATI Physical Therapy$0.99-1.0%$0.91$0.41▼$6.59$4.37M-0.1537,908 shs1,830 shsBLTEBelite Bio$59.74+5.2%$61.72$43.70▼$86.53$1.90B-1.545,968 shs64,433 shsIRONDisc Medicine$54.75+3.0%$49.35$30.82▼$68.73$1.90B0.76339,682 shs218,300 shsSNDAShanda Interactive Entertainment$25.40+11.4%$0.00$19.34▼$33.25$479.80M1.8353,862 shs32,857 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATIPATI Physical Therapy0.00%+15.12%-1.00%+10.91%-80.20%BLTEBelite Bio0.00%+1.19%+0.10%+7.31%+31.30%IRONDisc Medicine0.00%+0.45%+9.45%+39.66%+17.43%SNDAShanda Interactive Entertainment0.00%+1.09%-0.11%+21.79%-14.01%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationATIPATI Physical Therapy0.191 of 5 stars0.03.00.00.00.01.70.0BLTEBelite Bio2.4435 of 5 stars3.52.00.00.03.00.80.6IRONDisc Medicine3.0359 of 5 stars4.51.00.00.02.52.50.0SNDAShanda Interactive Entertainment0.5099 of 5 stars1.02.00.00.00.03.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATIPATI Physical Therapy 0.00N/AN/AN/ABLTEBelite Bio 3.00Buy$96.6761.81% UpsideIRONDisc Medicine 3.09Buy$96.7076.64% UpsideSNDAShanda Interactive Entertainment 2.00Hold$26.002.36% UpsideCurrent Analyst Ratings BreakdownLatest SNDA, ATIP, IRON, and BLTE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/3/2025BLTEBelite BioHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$100.007/3/2025IRONDisc MedicineMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$85.007/3/2025IRONDisc MedicineHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$118.006/17/2025IRONDisc MedicineHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$118.006/16/2025IRONDisc MedicineWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform$90.006/11/2025IRONDisc MedicineRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageStrong-Buy$89.005/20/2025SNDAShanda Interactive EntertainmentMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$25.00 ➝ $26.005/15/2025BLTEBelite BioCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight5/15/2025BLTEBelite BioHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$100.00 ➝ $100.005/12/2025IRONDisc MedicineBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$112.00 ➝ $120.00(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATIPATI Physical Therapy$741.86M0.01$5.21 per share0.19($23.96) per share-0.04BLTEBelite BioN/AN/AN/AN/A$4.72 per shareN/AIRONDisc MedicineN/AN/AN/AN/A$14.85 per shareN/ASNDAShanda Interactive Entertainment$255.32M1.90N/AN/A($14.07) per share-1.81Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATIPATI Physical Therapy-$69.79M-$19.42N/A∞N/A-7.79%N/A-3.87%7/7/2025 (Estimated)BLTEBelite Bio-$36.14M-$1.36N/AN/AN/AN/A-32.07%-30.91%8/8/2025 (Estimated)IRONDisc Medicine-$109.36M-$3.92N/AN/AN/AN/A-22.61%-21.07%8/6/2025 (Estimated)SNDAShanda Interactive Entertainment-$21.11M-$1.85N/AN/AN/A-4.02%N/A-6.11%N/ALatest SNDA, ATIP, IRON, and BLTE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025IRONDisc Medicine-$0.99-$1.02-$0.03-$1.02N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthATIPATI Physical TherapyN/AN/AN/AN/AN/ABLTEBelite BioN/AN/AN/AN/AN/AIRONDisc MedicineN/AN/AN/AN/AN/ASNDAShanda Interactive EntertainmentN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioATIPATI Physical TherapyN/A1.121.12BLTEBelite BioN/A24.3124.31IRONDisc Medicine0.0437.6537.65SNDAShanda Interactive Entertainment6.972.342.34Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATIPATI Physical Therapy72.60%BLTEBelite Bio0.53%IRONDisc Medicine83.70%SNDAShanda Interactive Entertainment87.55%Insider OwnershipCompanyInsider OwnershipATIPATI Physical Therapy3.30%BLTEBelite Bio13.29%IRONDisc Medicine4.24%SNDAShanda Interactive Entertainment5.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATIPATI Physical Therapy5,6004.41 million4.27 millionNo DataBLTEBelite Bio1031.84 million27.61 millionNot OptionableIRONDisc Medicine3034.63 million33.17 millionNot OptionableSNDAShanda Interactive Entertainment3,95519.07 million18.12 millionNot OptionableSNDA, ATIP, IRON, and BLTE HeadlinesRecent News About These CompaniesSonida Senior Living, Inc. (SNDA) Q1 2025 Earnings Call TranscriptMay 12, 2025 | seekingalpha.comSonida Senior Living (SNDA) Reports Q1 Loss, Tops Revenue EstimatesMay 12, 2025 | zacks.comSonida Senior Living Announces First Quarter 2025 ResultsMay 12, 2025 | businesswire.comSonida Announces Participation in Upcoming ConferencesMay 8, 2025 | businesswire.comThe Wellington at North Bend Crossing Expands Assisted Living and Memory Care Services, Coming Summer 2025May 2, 2025 | businesswire.comSonida Senior Living, Inc. (SNDA) Q4 2024 Earnings Call TranscriptMarch 17, 2025 | seekingalpha.comSonida Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference CallMarch 3, 2025 | businesswire.comSonida to Participate in Citi's 30th Annual Global Property CEO ConferenceFebruary 17, 2025 | businesswire.comSonida Senior Living Advances Clinical Excellence with August HealthFebruary 6, 2025 | businesswire.comSonida Announces Latest Asset Acquisition and Closing of Fannie Mae Maturity ModificationsJanuary 6, 2025 | businesswire.comSonida Senior Living, Inc. (SNDA) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comSonida Senior Living Announces Third Quarter 2024 ResultsNovember 13, 2024 | businesswire.comSonida Continues Executing on its Accretive Growth and Capital Allocation Strategy with $48 Million of InvestmentsNovember 5, 2024 | businesswire.comSunda Energy Share Chat (SNDA)November 4, 2024 | lse.co.ukInteractive Harry Potter art experience to open on Sentosa on Nov 22November 1, 2024 | straitstimes.comSSonida Announces Third Quarter 2024 Earnings Release Date and Conference CallOctober 29, 2024 | businesswire.comSonida to Participate in the BofA Securities 2024 Global Real Estate ConferenceSeptember 5, 2024 | businesswire.comShanda Interactive and Hurray! Enter Into Asset Sale AgreementAugust 19, 2024 | br.advfn.comSonida Senior Living First Quarter 2024 Earnings: EPS: US$2.32 (vs US$3.38 in 1Q 2023)May 12, 2024 | finance.yahoo.comSonida Enhances Executive Team and Board to Support Company GrowthMay 10, 2024 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge3 Tech Stocks You Can't Miss in This Market CycleBy Gabriel Osorio-Mazilli | June 17, 2025View 3 Tech Stocks You Can't Miss in This Market CycleWhiplash for Investors: AeroVironment's Confusing Stock SignalsBy Jeffrey Neal Johnson | July 2, 2025View Whiplash for Investors: AeroVironment's Confusing Stock SignalsAeroVironment Will Hit New Highs This Year: Bull Flag ConfirmedBy Thomas Hughes | June 25, 2025View AeroVironment Will Hit New Highs This Year: Bull Flag ConfirmedSNDA, ATIP, IRON, and BLTE Company DescriptionsATI Physical Therapy NYSE:ATIP$0.99 -0.01 (-1.00%) As of 07/3/2025 12:43 PM EasternATI Physical Therapy, Inc. operates as an outpatient physical therapy provider that specializes in outpatient rehabilitation and adjacent healthcare services in the United States. It offers a range of services to its patients, including physical therapy to treat spine, shoulder, knee, and neck injuries or pain; work injury rehabilitation services, work conditioning and work hardening; and hand therapy, aquatic therapy, functional capacity evaluation, sports medicine, and wellness programs. It also provides ATI worksite solutions comprising injury prevention programs, work-related injury assessment services, wellness offerings, and consultations for employers; proprietary electronic medical records (EMR) integration, caseload management, and continuing education in therapy treatments; and sports medicine, including on-site sports physical therapy, clinical evaluation and diagnosis, immediate and emergency care, nutrition programs, and concussion management services. The company offers outpatient physical therapy services under the ATI brand name. ATI Physical Therapy, Inc. was founded in 1996 and is based in Bolingbrook, Illinois.Belite Bio NASDAQ:BLTE$59.74 +2.93 (+5.16%) As of 07/3/2025 01:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States. The company's lead product candidate is LBS-008 (Tinlarebant), an orally administered once-a-day tablet for maintaining the health and integrity of retinal tissues in autosomal recessive Stargardt disease and geographic atrophy patients. It is also developing LBS-009, an anti-retinol binding protein 4 oral therapy that is in the preclinical development phase targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc is a subsidiary of Lin Bioscience International Ltd.Disc Medicine NASDAQ:IRON$54.74 +1.58 (+2.96%) Closing price 07/3/2025 01:04 PM EasternExtended Trading$54.74 0.00 (0.00%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.Shanda Interactive Entertainment NASDAQ:SNDAShanda Interactive Entertainment Limited (Shanda Interactive) is an interactive entertainment media company. The Company offers a range of entertainment content portfolio, including among other things, massively multiplayer online role-playing game (MMORPG), advanced casual games and browser-based games without user-end software through Shanda Games, online (Internet and wireless value added services (WVAS)) and offline literature publication through Cloudary Corporation, a social network game community, including among others, online chess and board games, e-sports game platform and table game platform through Shanda Casual Community, WVAS and music through Hurray and online video through Ku6. In February 2012, Shanda Interactive merged with Premium Lead Company Limited and New Era Investment Holding Ltd. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Correction Equals Opportunity in Domino’s Pizza Stock Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
